Division of Ophthalmology, Department of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.
Kikuna Yuda Eye Clinic, Yokohama, Japan.
Sci Rep. 2024 Oct 28;14(1):25692. doi: 10.1038/s41598-024-77160-9.
The lymphatic system is a crucial contributor to allograft rejection after corneal transplantation. However, no surgical procedures for the central pathway where conjunctival lymphatic vessels converge have been investigated. Therefore, we aimed to establish a murine model of lymphatic vessel ligation and evaluate its inhibitory effect on corneal allograft rejection. A tracer was used to visualise lymphatic vessels, and complications were evaluated. A surgical technique was developed to block the lymphatic vessels. Corneas from C57BL/6 mice were transplanted into BALB/c mice divided into two groups-one with and one without lymphatic vessel ligation, to evaluate their effects on allograft rejection. Graft opacity scores were evaluated for 8 weeks, and immunohistochemistry was used to quantify angiogenesis and lymphangiogenesis. 20% trypan blue used as a tracer showed clear inflow with no complications. The two sutures and cyanoacrylate glue combination demonstrated a blocking effect after 25 days and was thus used for lymphatic ligation. Three and nine out of fourteen eyes showed rejection at 8 weeks post-surgery in the lymphatic vessel ligation and control groups, respectively. Furthermore, neovascularisation and lymphangiogenesis significantly decreased in the lymphatic vessel ligation group. Overall, we present a novel therapeutic strategy for corneal transplantation.
淋巴系统是角膜移植后同种异体排斥反应的重要因素。然而,尚未研究结膜淋巴管汇聚的中央通路的任何手术程序。因此,我们旨在建立一种淋巴管结扎的小鼠模型,并评估其对角膜同种异体排斥反应的抑制作用。使用示踪剂来可视化淋巴管,并评估并发症。开发了一种阻断淋巴管的手术技术。将 C57BL/6 小鼠的角膜移植到 BALB/c 小鼠中,分为两组 - 一组进行淋巴管结扎,另一组不进行淋巴管结扎,以评估它们对同种异体排斥反应的影响。对移植物混浊评分进行了 8 周的评估,并通过免疫组织化学定量分析血管生成和淋巴管生成。作为示踪剂的 20%台盼蓝显示出清晰的流入,没有并发症。在 25 天后,双缝线和氰基丙烯酸酯胶组合显示出阻断作用,因此用于淋巴管结扎。在淋巴管结扎组和对照组中,分别有 3 只和 9 只眼睛在手术后 8 周出现排斥反应。此外,淋巴管结扎组的新生血管和淋巴管生成明显减少。总之,我们提出了一种角膜移植的新治疗策略。